Modified expression of cytoplasmic isocitrate dehydrogenase electrophoretic isoforms in seminal plasma of men with sertoli-cell-only syndrome and seminoma

Molecular Carcinogenesis

Volumn 47, Issue 6, 2008, Pages 410-414

  Starita Geribaldi, Mireille ^a   Samson, Michel ^a   Guigonis, Jean Marie ^a   Pointis, Georges ^a   Fenichel, Patrick ^a  

^a INSERM   (France)

Author keywords

Cytoplasmic isocitrate dehydrogenase; Mass spectrometry; Spermatogenesis impairment; Testicular seminoma; Two dimensional gel electrophoresis

Indexed keywords

ISOCITRATE DEHYDROGENASE;

ADULT; ARTICLE; CLINICAL ARTICLE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMINAL PLASMA; SEMINOMA; SERTOLI CELL ONLY SYNDROME; SYNDROME;

CYTOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; ISOCITRATE DEHYDROGENASE; MALE; SEMEN; SEMINOMA; SERTOLI CELL-ONLY SYNDROME; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TESTICULAR NEOPLASMS;

EID: 44949256374     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20401     Document Type: Article

References (24)

1. Raman JD, Norbert CF, Goldstein M. Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis. J Urol 2005;174:1819-1822.
2. Husrnan DA. Cryptorchidism and its relationship to testicular neoplasia and microlithiasis. Urology 2005;66:424-426.
3. Rajpert-De Meyts E. Developmental model for the pathogenesis of testicular carcinoma in situ: Genetic and environmental aspects. Hum Reprod Update 2006;12:303-323.
4. Hoei-Hansen CE, Holm M, Rajpert-De Meyts E, Skakkebaek NE. Histological evidence of testicular dysgenesis in contralateral biopsies from 218 patients with testicular germ cell cancer. J Pathol 2003;200:370-374.
5. Iczkowski KA, Butler SL. New immunohistological markers in testicular tumors. Anal Quant Cytol Histol 2006;28:181-187.
6. Hoei-Hansen CE, Carlsen E, Jorgensen N, et al. Towards a non-invasive method for early detection of testicular neoplasia in semen samples by identification of fetal germ-cell-specific markers. Hum Reprod 2007;22:167-173.
7. Fenichel P, Rey R, Poggioli S, Donzeau M, Chevallier D, Pointis G. Anti-Müllerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia. Hum Reprod 1999;14:2020-2024.
8. Starita-Geribaldi M, Poggioli S, Zucchini M, et al. Mapping of seminal plasma proteins by two-dimensional gel electrophoresis in men with normal and impaired spermatogenesis. Mol Hum Reprod 2001;3:1611-1619.
9. Starita-Geribaldi M, Roux F, Garin J, Chevallier D, Fenichel P, Pointis G. Development of narrow immobilized pH gradients covering one pH unit for human seminal plasma proteomic analysis. Proteomics 2003;3:1611-1619.
10. Cayatte C, Pons C, Guigonis JM, et al. Protein profiling of rat ventral prostate following chronic finasteride administration. Mol Cell Proteomics 2006;5:2031-2043.
11. Seldenfeld J, Marton LJ. Biochemical markers of central nervous system tumors measured in cerebrospinal fluid and their potential use in diagnosis and patient management. J Natl Cancer Inst 1979;63:919-931.
12. Sharma A, Dharker SR, Dharker RS, Chatterji AK. Isocitric dehydrogenase of the cerebrospinal fluid in brain tumours and meningitis. Ind J Med Res 1980;72:458-460.
13. Bajo M, Fruehauf J, Kim SH, Fountoulakis M, Lubec G. Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex. Proteomics 2002;2:1539-1546.
14. 18O isotopic labeling. J Proteome Res 2004;3:604-612.
15. Qi Y, Chiu JF, Wang L, Kwong DL, He QY. Comparative proteomic analysis of oesophageal squamous cell carcinoma. Proteomics 2005;5:2960-2971.
16. Memon AA, Chang JW, Oh BR, Yoo YJ. Identification of differentially expressed proteins during human urinary bladder cancer progression. Cancer Detect Prev 2005;29: 249-255.
17. Otto VI, Schär BK, Sulser T, Hänseler E. Specific determination of germ cell alkaline phosphatase for early diagnosis and monitoring of seminoma: Performance and limitations of different analytical techniques. Clin Chim Acta 1998;273: 131-147.
18. von Eyben FE. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors. Clin Biochem 2001;34: 441-454.
19. von Eyben FE. Laboratory markers and germ cell tumours. Crit Rev Clin Lab Sci 2003;40:377-427.
20. +-dependent isocitrate dehydrogenase status modulates oxidative damage to cells. Free Radic Biol Med 2002;32: 1185-1196.
21. +-dependent isocitrate dehydrogenase. J Biol Chem 1999;274:30527-33533.
22. Valko M, Rhodes CJ, Moncol J, Izakonic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress induced cancer. Chem Biol Interact 2006;160:1-40.
23. +-dependent isocitrate dehydrogenase by reactive oxygen species. Biochimie 2001;83:1057-1065.
24. Xu X, Zhao J, Xu Z, et al. Structures of human cytosolic NADP+-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity. J Biol Chem 2004;279: 33946-33957.